Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology

ARTARMON , Australia, Dec. 20, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced The Lancet Neurology journal published results from the U.S. Pivotal Study demonstrating its Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System provided...

from PR Newswire: https://ift.tt/34EmnAh